Promotion or remission: a role of noncoding RNAs in colorectal cancer resistance to anti-EGFR therapy

Anti-epidermal-growth-factor-receptor (EGFR) monoclonal antibodies (mAbs) are of great significance for RAS and BRAF wild-type metastatic colorectal cancer (mCRC) patients. However, the generation of primary and secondary resistance to anti-EGFR mAbs has become an important factor restricting its ef...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Shanshan, Hu, Wenwei, Feng, Jun, Geng, Yiting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9490904/
https://www.ncbi.nlm.nih.gov/pubmed/36131281
http://dx.doi.org/10.1186/s12964-022-00960-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9490904/
https://www.ncbi.nlm.nih.gov/pubmed/36131281
http://dx.doi.org/10.1186/s12964-022-00960-x

Ejemplares similares